Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
256,711
-
Shares change
-
+3,218
-
Total reported value, excl. options
-
$1,251,000
-
Value change
-
+$15,585
-
Number of buys
-
3
-
Number of sells
-
-1
-
Price
-
$4.87
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q4 2014
11 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q4 2014.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 256,711 shares
.
Largest 10 shareholders include HealthInvest Partners AB (106,550 shares), SHUFRO ROSE & CO LLC (52,968 shares), GRT CAPITAL PARTNERS LLC (34,467 shares), Essex Financial Services, Inc. (23,776 shares), RENAISSANCE TECHNOLOGIES LLC (19,200 shares), VANGUARD GROUP INC (10,475 shares), MORGAN STANLEY (5,103 shares), BANK OF AMERICA CORP /DE/ (2,032 shares), UBS Group AG (1,000 shares), and Tower Research Capital LLC (TRC) (830 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.